Literature DB >> 22855491

Structural basis for the recognition of Lewis antigens by genogroup I norovirus.

Tomomi Kubota1, Akiko Kumagai, Hiromi Ito, Sanae Furukawa, Yuichi Someya, Naokazu Takeda, Koji Ishii, Takaji Wakita, Hisashi Narimatsu, Haruko Shirato.   

Abstract

Noroviruses (NoVs) bind to histo-blood group antigens, namely, ABH antigens and Lewis antigens. We previously showed the NoVs GI/2, GI/3, GI/4, and GI/8 were able to strongly bind to Lewis a (Le(a)) antigen, which is expressed by individuals who are nonsecretors. In this study, to investigate how Lewis antigens interact with GI NoV virion protein 1 (VP1), we determined the crystal structures of the P domain of the VP1 protein from the Funabashi 258 (FUV258) strain (GI/2) in complexes with Le(a), Le(b), H type 1, or A type 1 antigens. The structures were compared with those of the NV/68 strain (GI/1), which does not bind to the Le(a) antigen. The four loop structures, loop P, loop S, loop A, and loop B, continuously deviated by more than 2 Å in length between the Cα atoms of the corresponding residues of the FUV258 and NV/68 P domains. The most pronounced differences between the two VP1 proteins were observed in the structures of loop P. In the FUV258 P domain, loop P protruded toward the next protomer, forming a Le(a) antigen-binding site. The Gln389 residue make a significant contribution to the binding of the Le(a) antigen through the stabilization of loop P as well as through direct interactions with the α4-fucosyl residue (α4Fuc) of the Le(a) antigen. Mutation of the Gln389 residue dramatically affected the degree of binding of the Lewis antigens. Collectively, these results suggest that loop P and the amino acid residue at position 389 affect Lewis antigen binding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855491      PMCID: PMC3457155          DOI: 10.1128/JVI.00278-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Wide variety of point mutations in the H gene of Bombay and para-Bombay individuals that inactivate H enzyme.

Authors:  M Kaneko; S Nishihara; N Shinya; T Kudo; H Iwasaki; T Seno; Y Okubo; H Narimatsu
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  Interaction of recombinant norwalk virus particles with the 105-kilodalton cellular binding protein, a candidate receptor molecule for virus attachment.

Authors:  M Tamura; K Natori; M Kobayashi; T Miyamura; N Takeda
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 3.  Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle.

Authors:  Ming Tan; Xi Jiang
Journal:  Trends Microbiol       Date:  2005-06       Impact factor: 17.079

4.  Norwalk virus infection and disease is associated with ABO histo-blood group type.

Authors:  Anne M Hutson; Robert L Atmar; David Y Graham; Mary K Estes
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

5.  In vitro and in vivo enzymatic syntheses and mass spectrometric database for N-glycans and o-glycans.

Authors:  Hiromi Ito; Yasunori Chiba; Akihiko Kameyama; Takashi Sato; Hisashi Narimatsu
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

6.  Sequence and genomic organization of Norwalk virus.

Authors:  X Jiang; M Wang; K Wang; M K Estes
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors.

Authors:  Ming Tan; Rashmi S Hegde; Xi Jiang
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals.

Authors:  Severine Marionneau; Nathalie Ruvoën; Beatrice Le Moullac-Vaidye; Monique Clement; Anne Cailleau-Thomas; Guillermo Ruiz-Palacois; Pengwei Huang; Xi Jiang; Jacques Le Pendu
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  30 in total

1.  The Campylobacter jejuni chemoreceptor Tlp10 has a bimodal ligand-binding domain and specificity for multiple classes of chemoeffectors.

Authors:  Bassam A Elgamoudi; Ekaterina P Andrianova; Lucy K Shewell; Christopher J Day; Rebecca M King; Hossinur Rahman; Lauren E Hartley-Tassell; Igor B Zhulin; Victoria Korolik
Journal:  Sci Signal       Date:  2021-01-05       Impact factor: 8.192

2.  Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses.

Authors:  Takayuki Miura; Daisuke Sano; Atsushi Suenaga; Takeshi Yoshimura; Miyu Fuzawa; Toyoko Nakagomi; Osamu Nakagomi; Satoshi Okabe
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

3.  Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody.

Authors:  Sreejesh Shanker; Rita Czakó; Gopal Sapparapu; Gabriela Alvarado; Maria Viskovska; Banumathi Sankaran; Robert L Atmar; James E Crowe; Mary K Estes; B V Venkataram Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

4.  Human noroviruses' fondness for histo-blood group antigens.

Authors:  Bishal K Singh; Mila M Leuthold; Grant S Hansman
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

5.  Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay.

Authors:  Ling Han; Elena N Kitova; Ming Tan; Xi Jiang; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2013-10-05       Impact factor: 3.109

Review 6.  Epidemiology of human noroviruses and updates on vaccine development.

Authors:  Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  Curr Opin Gastroenterol       Date:  2014-01       Impact factor: 3.287

7.  Structural Basis for Norovirus Inhibition by Human Milk Oligosaccharides.

Authors:  Stefan Weichert; Anna Koromyslova; Bishal K Singh; Satoko Hansman; Stefan Jennewein; Horst Schroten; Grant S Hansman
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

8.  Identification of human single-chain antibodies with broad reactivity for noroviruses.

Authors:  Wanzhi Huang; Moumita Samanta; Sue E Crawford; Mary K Estes; Frederick H Neill; Robert L Atmar; Timothy Palzkill
Journal:  Protein Eng Des Sel       Date:  2014-06-19       Impact factor: 1.650

Review 9.  Structural basis of glycan interaction in gastroenteric viral pathogens.

Authors:  B V Venkataram Prasad; Sreejesh Shanker; Liya Hu; Jae-Mun Choi; Sue E Crawford; Sasirekha Ramani; Rita Czako; Robert L Atmar; Mary K Estes
Journal:  Curr Opin Virol       Date:  2014-07-27       Impact factor: 7.090

Review 10.  Antiviral targets of human noroviruses.

Authors:  Bv Venkataram Prasad; Sreejesh Shanker; Zana Muhaxhiri; Lisheng Deng; Jae-Mun Choi; Mary K Estes; Yongcheng Song; Timothy Palzkill; Robert L Atmar
Journal:  Curr Opin Virol       Date:  2016-06-17       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.